Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

Clinical trial NCT02976896 · COMPLETED

Trial details

NCT number: NCT02976896
Sponsor: Yuhong Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2016-08-01
Primary completion: 2019-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.